Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)

Exclusion Criteria

• •* Subjects with coexisting tuberculous disease or lower respiratory tract infection and subjects who have a nasopharyngolaryngeal infection (acute upper respiratory tract infection, acute pharyngolaryngitis, or acute tonsillitis, etc.) requiring treatment at the time of registration
• •* Subjects with coexisting infections or systemic mycosis for which there are no effective antibiotics
• •* Subjects with repeated epistaxis
• •* Subjects who have nasal septum ulcers, nasal surgery, or nasal trauma, which have not healed
• •* Subjects with severe hepatic, renal, cardiac, hematological disease, diabetes mellitus, hypertension, or other serious coexisting diseases and whose general condition is poor
• •* Subjects with complication of vasomotor rhinitis or eosinophilic rhinitis.
• •* Subjects with nasal conditions (infectious sinusitis, hypertrophic rhinitis, acute or chronic rhinitis, nasal polyps, septal deviation, etc.) which may interfere with the evaluation of the efficacy of the study drug.